Pediatric Preclinical Testing Program (PPTP)

Peter Houghton, Ph. D. | Lead Principal Investigator

Dr. Malcolm Smith | NCI Program Officer

Pediatric Preclinical Testing Program - Compare Charts

Visual representation of tumor sensitivity based on the difference of individual tumor lines from the midpoint response (stable disease). Bars to the right of the median represent lines that are more sensitive (objective response), and to the left are tumor models that are less sensitive (progressive disease). Red bars indicate lines with a significant difference in EFS distribution between treatment and control groups, while blue bars indicate lines for which the EFS distributions were not significantly different.

© 2009 | Columbus Children's Hospital is now Nationwide Children's Hospital.